COMMON BRAND NAME(S): Neumega
GENERIC NAME(S): OPRELVEKIN
Description: Oprelvekin is a recombinant human interleukin-11 platelet factor that promotes the production of platelets.
Pharmacokinetics:
Absorption: Bioavailability: About 80% (SC). Peak serum concentrations after about 3 hr.
Excretion: Via urine (mainly as metabolites). Clearance reduced in renal impairment. Terminal half-life: 7 hr.